DSW (NYSE: DSW), Regeneron Pharma (NASDAQ: REGN), Rockwell Medical (NASDAQ: RMTI), Rofin-Sinar Technologies (NASDAQ: RSTI), Double Eagle Petroleum (NASDAQ: DBLE) and Douglas Emmett (NYSE: DEI) were upgraded by analysts.
Regeneron Pharma (REGN) was upgraded by Robert W. Baird from a “Neutral” rating to an “Outperform” rating. They have a price target of $81.00 on the company, up from $56.00.
Rockwell Medical (RMTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.
Rofin-Sinar Technologies (RSTI) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.
Double Eagle Petroleum (DBLE) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.
Douglas Emmett (DEI) was upgraded by Raymond James (NYSE:RJF) from a “Market Perform” rating to an “Outperform” rating.
DSW (DSW) was upgraded by Zacks Investment Research from a “Neutral” rating to an “Outperform” rating.
Showing posts with label DSW. Show all posts
Showing posts with label DSW. Show all posts
Wednesday, January 11, 2012
DSW (DSW) (REGN) (RMTI) (RSTI) (DBLE) (DEI) Upgraded
Wednesday, August 10, 2011
DSW (DSW) (TNB) (NBIX) (FSL) (MITT) Get New Coverage
DSW Inc. (NYSE: DSW), Thomas & Betts Co. (NYSE: TNB), Neurocrine Biosciences Inc. (NASDAQ: NBIX), Freescale Semi (NYSE: FSL) and AG Mortgage Investment Trust (NASDAQ: MITT) getting new analyst coverage.
Macquarie initiated coverage on Thomas & Betts Co. (TNB). They placed a “Neutral” rating on the company.
Avondale Partners initiated coverage on DSW Inc. (DSW). They placed an “Outperform” rating and a price target of $50.00 on the company.
MKM Partners initiated coverage on Neurocrine Biosciences Inc. (NBIX). They placed a “Buy” rating and a price target of $12.00 on the company.
Gleacher & Co. initiated coverage on Freescale Semi (FSL). The y placed a “Buy” rating on the company.
Stifel Nicolaus initiated coverage on AG Mortgage Investment Trust (MITT). They placed a “Buy” rating and a price target of $22.00 on the company.
Macquarie initiated coverage on Thomas & Betts Co. (TNB). They placed a “Neutral” rating on the company.
Avondale Partners initiated coverage on DSW Inc. (DSW). They placed an “Outperform” rating and a price target of $50.00 on the company.
MKM Partners initiated coverage on Neurocrine Biosciences Inc. (NBIX). They placed a “Buy” rating and a price target of $12.00 on the company.
Gleacher & Co. initiated coverage on Freescale Semi (FSL). The y placed a “Buy” rating on the company.
Stifel Nicolaus initiated coverage on AG Mortgage Investment Trust (MITT). They placed a “Buy” rating and a price target of $22.00 on the company.
Labels:
AG Mortgage,
DSW,
Freescale,
Neurocrine,
Thomas and Betts
Tuesday, May 3, 2011
Coverage on (AVL) (DSW) (FSRV) (HTWR) Initiated
Avalon Rare Metals (NYSE: AVL), DSW Inc. (NYSE: DSW), FirstService Co. (NASDAQ: FSRV) and HeartWare (NASDAQ: HTWR) had coverage initiated on them today by analysts.
Dahlman Rose initiated coverage on Avalon Rare Metals (AVL). They placed a “buy” rating and a price target of $15.00 on the company.
Capstone initiated coverage on DSW Inc. (DSW). They set a “buy” rating on the company.
JMP Securities initiated coverage on FirstService Co. (FSRV). They set an “outperform” rating and a price target of $45.00 on the company.
Bank of America (NYSE:BAC) initiated coverage on HudBay Minerals (HBM). They placed a “buy” rating and a price target of $20.00 on the company.
Wunderlich initiated coverage on HeartWare (HTWR). They placed a “hold” rating and a price target of $80.00 on the company.
Dahlman Rose initiated coverage on Avalon Rare Metals (AVL). They placed a “buy” rating and a price target of $15.00 on the company.
Capstone initiated coverage on DSW Inc. (DSW). They set a “buy” rating on the company.
JMP Securities initiated coverage on FirstService Co. (FSRV). They set an “outperform” rating and a price target of $45.00 on the company.
Bank of America (NYSE:BAC) initiated coverage on HudBay Minerals (HBM). They placed a “buy” rating and a price target of $20.00 on the company.
Wunderlich initiated coverage on HeartWare (HTWR). They placed a “hold” rating and a price target of $80.00 on the company.
Labels:
Avalon Rare Metals,
Bank of America,
DSW,
Firstservice
Subscribe to:
Posts (Atom)